Skip to content

A randomized controlled clinical study on improving the accuracy and efficiency of skeletal class III malocclusion patients by

A randomized controlled clinical study on improving the accuracy and efficiency of skeletal class III malocclusion patients by

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072436
Enrollment
Unknown
Registered
2023-06-13
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral and Craniofacial Surgery

Interventions

Test group:accurate tooth-bone movement surgery first approach
control group:orthodontics first approach

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) subjects aged 18 years or older, regardless of gender; (2) patients with skeletal class III malocclusion caused by developmental factors who were scheduled for orthognathic treatment with maxillary and mandibular surgery.

Exclusion criteria

Exclusion criteria: (1) patients with craniomaxillofacial syndrome and cleft lip and palate; (2) patients who had received orthognathic surgery and were treated with reoperation this time; (3) patients with craniomaxillofacial tumors and craniofacial deformities secondary to trauma; (4) patients who needed maxillary or mandibular segmental surgery; (5) patients whose Spee curve depth was greater than 3 mm; (6) Patients with extensive soft tissue defects caused by surgery and insufficient soft tissue coverage of the wound after surgery; (7) Patients with radiation osteomyelitis, acute and chronic osteomyelitis, and osteoporosis; (8) Patients with mental illness; (9) Patients who are unable to cooperate with the treatment; (10) Patients who are in critical condition and are difficult to make a definite evaluation of the effectiveness and safety of implants; (11) Participated in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
accuracy of the jaw after treatment;treatment time;

Secondary

MeasureTime frame
patient satisfaction;Number of orthodontic return visits;Cost;

Countries

China

Contacts

Public ContactXudong Wang

Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

xudongwang70@hotmail.com+86 138 1847 4330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026